Teacher Retirement System of Texas trimmed its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 8.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 215,234 shares of the company’s stock after selling 19,161 shares during the period. Teacher Retirement System of Texas owned about 0.17% of Clorox worth $25,843,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Clorox by 0.4% during the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock worth $2,293,135,000 after buying an additional 65,924 shares during the period. Northern Trust Corp increased its stake in shares of Clorox by 2.3% during the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock worth $225,133,000 after buying an additional 34,655 shares during the period. Invesco Ltd. increased its stake in shares of Clorox by 7.4% during the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock worth $200,512,000 after buying an additional 94,371 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Clorox by 3.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock worth $170,406,000 after buying an additional 41,485 shares during the period. Finally, Hsbc Holdings PLC increased its stake in shares of Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock worth $159,699,000 after buying an additional 589,544 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
Clorox Stock Performance
Shares of CLX opened at $115.59 on Tuesday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The firm has a market cap of $14.08 billion, a PE ratio of 17.73, a price-to-earnings-growth ratio of 0.96 and a beta of 0.52. The company’s 50 day simple moving average is $121.10 and its 200-day simple moving average is $126.68. The Clorox Company has a 12-month low of $114.95 and a 12-month high of $171.37.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.3%. Clorox’s dividend payout ratio (DPR) is 76.07%.
Insider Activity
In related news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.63% of the company’s stock.
Analysts Set New Price Targets
A number of analysts recently weighed in on CLX shares. JPMorgan Chase & Co. cut their target price on shares of Clorox from $135.00 to $127.00 and set a “neutral” rating on the stock in a research note on Friday, October 10th. Wells Fargo & Company dropped their price target on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 25th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a research note on Monday, October 13th. UBS Group dropped their price target on shares of Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Finally, The Goldman Sachs Group dropped their price target on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research note on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $130.20.
Check Out Our Latest Stock Analysis on CLX
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Compound Interest and Why It Matters When Investing
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- How to Calculate Return on Investment (ROI)
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- Best Stocks Under $5.00
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
